Psychocare Health Private Limited is a reputed and trusted PCD pharma company in India that began its journey in 2013, initially known as (founded in 2005). As a quality-driven and ethical neuro pharma PCD company in India, our mission is straightforward: to enhance healthcare outcomes while establishing ourselves as the leading PCD pharma company specializing in neuropsychiatry.
Recognizing the increasing demand for neuro and psychiatry medications, we have positioned ourselves as a top pharmaceutical company offering PCD franchise solutions. Our extensive range includes over 1,200 high-quality products, spread across four divisions and three sister concerns, making us a top player among PCD pharma companies in India with a diverse and reliable product range. Through our nationwide network of franchisees, we ensure the timely delivery of superior neuropsychiatric, psychiatric, and general medicines.
We are an ISO 9001:2015 certified and GMP-compliant PCD pharmaceutical company, committed to maintaining international quality standards. Our manufacturing operations strictly follow WHO-GMP norms, ensuring every product meets the highest benchmarks of safety and efficacy. In FY 2019–20, we achieved a turnover of Rs. 27+ crores, which rose to Rs. 33+ crores in FY 2020–21—demonstrating our consistent growth in the PCD franchise business.
As one of the best neuropsychiatry PCD pharma companies, Psychocare is driven by innovation, customer satisfaction, and consistent quality. We offer competitive pricing, superior stock availability, and ethical business practices—making us a preferred partner for entrepreneurs looking to establish a PCD pharma business in India. If you're seeking a trusted name in the PCD pharma company in India, Psychocare stands out as a reliable and future-focused choice.
At Psychocare Health, our mission is to improve lives through better healthcare solutions. As an experienced pharma company offering PCD services, we focus on quality drug formulations in neurology, psychiatry, and cardiac care. As a top neuropsychiatry PCD pharma company, we have set a benchmark for consistent improvement in research, manufacturing, and marketing.
Based in Mohali, we are recognized as one of the leading neuro pharma PCD companies in India, committed to innovation and flexibility. Our ability to constantly upgrade our product portfolio and adapt to market dynamics helps us stand out as an Indian PCD pharma company. We strive to meet every customer’s expectations and are determined to become a globally recognized pharma company in India by introducing an expansive range of PCD franchise and pharma franchise company opportunities.
We envision becoming a reputed pharma company for neuropsychiatry products, offering ethical and accessible healthcare solutions across India and beyond.
Psychocare Health Private Limited (PCHPL) aims to lead as an ethical pharmaceutical PCD company in India, with a strong emphasis on innovation, quality, and affordability. As a company profile of PCD pharma franchise, our vision is to deliver top-quality and cost-effective pharmaceutical solutions while supporting franchise partners across the country.
Our modern manufacturing unit, backed by ISO certification and WHO-GMP compliance, reflects our commitment to global standards. We take pride in being a quality-driven PCD pharma franchise company in India, delivering value through our wide and effective product range.
With a clear roadmap, we aim to establish our presence in every state and district of India as a top PCD franchise company, growing as a global neuropsychiatry pharma company known for reliability, competence, and innovation.
Through consistent research, strategic partnerships, and customer-centric practices, we aspire to become a world-class pharma company in India and a leader in the neuro, psychiatry, and cardiac segments.
On June 29, 2024, this company proudly received the "Best Enterprise of the Year (Pharmaceutical)" 4th award from MSME India Business. The accolade recognizes their dedication to excellence, innovation, and quality.
In 2021-22, our director, Mr Supreet Singh, received the "Brand Impact" award from the Indian Achievers Forum. This award highlights his outstanding influence and leadership in driving the company's success and enhancing its industry presence.
On July 17, 2019, we were honored with the Business Excellence Award from CIMS for our achievements in neuropsychiatric products. This recognition underscores our outstanding contributions and innovation in the field.
Co-Founder and M.D.
Founder and Director
Trusted by 200+ popular brands